Events & Presentations

Upcoming Events
Date Event Details Remind Me
May 3, 2017
8:40 AM ET
Deutsche Bank 42nd Annual Health Care Conference

Deutsche Bank 42nd Annual Health Care Conference

Remind Me

Please sign up for Email alerts.


Archived Events
Date Event Details
Apr 2, 2017
9:00 AM ET
INVESTOR PRESENTATION: Clinical Results from Phase 1b Study of PRX002/RG7935 in Patients with Parkinson's Disease presented at AD/PD 2017
Mar 21, 2017
8:35 AM ET
Oppenheimer 27th Annual Healthcare Conference
Location: New York, NY
Mar 16, 2017
10:15 AM ET
Barclays Global Healthcare Conference
Location: Miami, FL
Feb 22, 2017
1:35 PM ET
RBC Capital Markets 2017 Global Healthcare Conference
Location: New York, NY
Feb 16, 2017
11:30 AM ET
Leerink Partners 6th Annual Global Healthcare Conference
Feb 14, 2017
4:30 PM ET
Prothena Fourth Quarter and Full Year 2016 Financial Results Conference Call
Jan 12, 2017
11:00 AM PT
35th Annual J.P. Morgan Healthcare Conference
Dec 4, 2016
8:00 AM PT
ORAL PRESENTATION: Organ Biomarker Responses in Patients With Light Chain Amyloidosis Treated With NEOD001 Are Independent of Previous Hematologic Responses Presentation at the 58th ASH Annual Meeting Dr. Michaela Liedtke of Stanford University School of Medicine on NEOD001, Prothena's investigational antibody for the potential treatment of AL amyloidosis. Safety and efficacy of NEOD001 are being further evaluated in two late stage clinical studies.
Dec 4, 2016
7:15 AM PT
ORAL PRESENTATION: NEOD001 Demonstrates Organ Biomarker Responses in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Final Results From a Phase 1/2 Study Presentation at the 58th ASH Annual Meeting Dr. Morie Gertz of Mayo Clinic on NEOD001, Prothena's investigational antibody for the potential treatment of AL amyloidosis. Safety and efficacy of NEOD001 are being further evaluated in two late stage clinical studies.
Sep 29, 2016
4:30 PM ET
PRX003 Investor Update: Phase 2 Development Strategy
Sep 27, 2016
10:00 AM ET
The Ladenburg Thalmann 2016 Healthcare Conference
Sep 7–8, 2016
Credit Suisse Antibody Day – 9/7
Citi's 11th Annual Biotech Conference – 9/8
Jul 12, 2016
11:45 AM ET
Cantor Fitzgerald's 2nd Annual Healthcare Conference
Jul 5, 2016
10:30 AM ET
INVESTOR PRESENTATION: New clinical data from Phase 1/2 Study of NEOD001 in Previously-Treated Patients with AL Amyloidosis presented at ISA 2016
Jun 11, 2016
POSTER: The Relative Burden of AL Amyloidosis on Health-related Quality of Life presented at the 21st Congress of the European Hematology Association
Jun 10, 2016
11:20 AM UK
ORAL PRESENTATION: Clinical and Preclinical Assessment of the Anti-MCAM Monoclonal Antibody PRX003 presented at EULAR
Jun 10, 2016
POSTER: Treatment History, Tolerability and Impact on Health-Related Quality of Life in AL Amyloidosis presented at the 21st Congress of the European Hematology Association
Jun 10, 2016
POSTER: The Impact of AL Amyloidosis on Absenteeism, Reduced Productivity and Job Loss presented at the 21st Congress of the European Hematology Association
Jun 10, 2016
POSTER: Psychometric Validation of the SF-36V2® Health Survey in an AL Amyloidosis Population presented at the 21st Congress of the European Hematology Association
Jun 9, 2016
4:30 PM ET
INVESTOR PRESENTATION: Clinical Data from a Phase 1 Single Ascending Dose Study of PRX003, An Anti-MCAM Antibody for Inflammatory Diseases
Jun 6, 2016
POSTER: Trial design of the PRONTO Amyloidosis Study: A Randomized, Double-Blind,Placebo-Controlled, Global, Phase 2b Study of NEOD001 in Previously Treated Patients With Light Chain Amyloidosis and Persistent Cardiac Dysfunction, presented at ASCO 2016
= add file to Briefcase